YRC Worldwide, Inc. (YRCW), Sarepta Therapeutics Inc (SRPT), Christopher & Banks Corporation (CBK): Russell Rebalance Could Push These Stocks Even Higher!

Page 1 of 2

Last year, these three stocks weren’t even on the radar of most retail investors, but have since returned incredible gains. Now, another catalyst could catapult each even higher, along with continued fundamental improvements.

What Are The Russell Indexes?

The Russell Indexes combined are tracked by more than $4 trillion, meaning that institutional and retail investors alike invest in their indexes more so than all other U.S. equity indexes combined. Among its offerings, are the Russell 2000, 3000, and Global indexes, which are among the most popular.

On Friday, Russell indexes began the process of rebalancing, which means purchasing new stocks and selling others. Those that are sold, no longer qualify, either falling below the requirements or being above the requirements.

Those that are purchased are typically IPOs or stocks that now meet certain requirements, while they may not have in the year prior. In this piece, I am looking at three such stocks; they are stocks that could move considerably higher with the rebalancing of Russell indexes.

YRC Worldwide, Inc. (NASDAQ:YRCW)

From Bankruptcy To Large Gains

Last year, YRC Worldwide, Inc. (NASDAQ:YRCW) was a $50 million company, today it is valued at $265 million. Its large gains have come after the company posted its first quarter of operating profit in many years’ time.

Moreover, the company is in talks to acquire a fellow trucking company, Arkansas Best, a company growing at more than 15% annually with over $2 billion in annual revenue. Currently, YRC Worldwide, Inc. (NASDAQ:YRCW) trades at 0.05 times sales, which is by far the cheapest in the transportation sector.

If the company can continue to improve then large gains can be created. On Friday, gains of almost 2% occurred due to it being added to the Russell funds. Thus, I’d watch this stock over the next week, as it trades near 52-week highs.

Unprecedented Data & Large Sales Potential Have Pushed This Stock Higher

Sarepta Therapeutics Inc (NASDAQ:SRPT) did not qualify for Russell funds last year, trading with a market cap of just $100 million. However, on Friday, it was added to both the Global and 3000 Russell indexes with a market cap of $1.2 billion.

Sarepta Therapeutics Inc (NASDAQ:SRPT)’ large gains were created after data for its Phase 2 Orphan candidate Eteplirsen for the treatment of Duchenne Muscular Dystrophy. Currently, there are no approved products for this disease, and analysts project that it could result in revenue of $700 million annually.

The company is awaiting an FDA decision on whether or not Eteplirsen’s approval can be accelerated. Sarepta Therapeutics Inc (NASDAQ:SRPT) continues to trade higher, as continuous checks on data from the Phase 2 trial indicate a drug that improves the outcome of the disease with time. With its institutional ownership on the rise, over the last year, I’d watch this stock, as the Russell inclusion could push shares even higher.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

The 10 Largest Container Shipping Companies in the World

The 10 Largest Armies in the World: Who Should We Be Afraid Of?

Best Warren Buffett Quotes on Money You Need to Hear

The 10 Highest Suicide Rates by Profession

The 20 Most Underrated Movies of All Time

The 10 Fastest Growing Companies in America

The 10 Biggest Outlet Malls in USA

The 5 Most Popular Rap Songs of All Time

The 10 Countries that Eat the Most Meat

The10 Most Expensive Countries to Fly To

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!